In: Nursing
The Instructor will assign ten (10) drug cards per week, in specific areas. Each card will be worth 1 point. You will not receive the points for the cards if they are not submitted within the week when due.
· Cards must be handwritten, legible, and on ruled index cards.
· All information required on the card must be completed or you will not receive the point for the card.
· The following information must be on the Drug Card for Each Drug:
1. Quidine
2. Procainamide
3. Cialis
4. Nadolol
5. Ranexa
6. Adenosine
7. Xarelto
8. Eliquis
9. Pradaxa
10. Urokinase
11 Celexia
12 Remeron
`13 epinephrine
14 cymbalta
15 Naproxen
| 
 Drug:-  | 
 Quidine  | 
| 
 Generic:-  | 
 Quinidine Gluconate  | 
| 
 trade name:-  | 
 Cardioquin Tablets  | 
| 
 Classification:-  | 
 Anti-arrhythmic drug  | 
| 
 Therapeutics:-  | 
 prevent ventricular arrhythmias  | 
| 
 Pharmacological:-  | 
 Half- life of 6-8 hours Quinidine acts as a blocker of voltage-gated sodium channels. Quinidine's effect on (sodium) INa is known as a 'use dependent block'. This means at higher heart rates, the block increases, while at lower heart rates, it decreases  | 
| 
 Indications/uses:-  | 
 ventricular pre-excitation and cardiac dysrhythmias  | 
| 
 Contraindications:-  | 
 Complete AV block, severe intra-ventricular conduction defects, left bundle-branch block, or ventricular ectopic.  | 
| 
 Adverse reactions:-  | 
 · Diarrhoea. · Nausea. · Vomiting. · Loss of appetite. · Stomach pain/cramps. · A burning feeling in throat or chest (e.g., heartburn) · Light headedness. · Headache.  | 
| 
 Safe dosage range:-  | 
 100 mg/1 and 324 mg/1 in extended release  | 
| 
 Nursing implications  | 
 · Avoid eating grapefruit or drinking grapefruit juice while being treated with this medication · Take this medication by mouth with or without food with a full glass of liquid (8 ounces/240 millilitres) · Do not crush or chew extended-release tablets  | 
| 
 Drug:-  | 
 Procainamide  | 
| 
 Generic:-  | 
 Apo-procainamide  | 
| 
 trade name:-  | 
 Procan SR  | 
| 
 Classification:-  | 
 Sodium channel blocker  | 
| 
 Therapeutics:-  | 
 prevent ventricular arrhythmias  | 
| 
 Pharmacological:-  | 
 Half- life of 2.5-4.5 hours This drug induces rapid block of the batrachotoxin (BTX)-activated sodium channels of the heart muscle and acts as antagonist to long-gating closures.  | 
| 
 Indications/uses:-  | 
 Ventricular arrhythmias: ventricular ectopic and tachycardia and supraventricular arrhythmias: atrial fibrillation, and re-entrant and automatic supraventricular tachycardia.  | 
| 
 Contraindications:-  | 
 · High levels of potassium in the blood. · Low amount of potassium in the blood. · Decreased blood platelets. · Very low levels of granulocytes. · A type of white blood cell. · Myasthenia gravis. · A skeletal muscle disorder. · Heart attack within the last 30 days  | 
| 
 Adverse reactions:-  | 
 Nausea, vomiting, loss of appetite, diarrhoea, bitter taste in the mouth, dizziness, tired feeling, flushing (warmth, redness, or tingly feeling), and itching or rash.  | 
| 
 Safe dosage range:-  | 
 250 mg/1 and 500 mg/1 in extended release  | 
| 
 Nursing implications  | 
 · Drug interacts with diabetes medicine · Drug sometimes interacts with vitamins · It could also cause systemic lupus erythematous · Can cause respiratory depression  |